- Home
- EDRY vs PYPD Comparison
EDRY vs PYPD Comparison
Compare EDRY & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDRY
- PYPD
- Stock Information
- Founded
- EDRY 2018
- PYPD 2008
- Country
- EDRY Greece
- PYPD Israel
- Employees
- EDRY N/A
- PYPD N/A
- Industry
- EDRY Marine Transportation
- PYPD Medical/Dental Instruments
- Sector
- EDRY Consumer Discretionary
- PYPD Health Care
- Exchange
- EDRY Nasdaq
- PYPD Nasdaq
- Market Cap
- EDRY 27.3M
- PYPD 36.0M
- IPO Year
- EDRY N/A
- PYPD 2020
- Fundamental
- Price
- EDRY $10.60
- PYPD $3.52
- Analyst Decision
- EDRY
- PYPD Strong Buy
- Analyst Count
- EDRY 0
- PYPD 5
- Target Price
- EDRY N/A
- PYPD $11.40
- AVG Volume (30 Days)
- EDRY 7.0K
- PYPD 199.2K
- Earning Date
- EDRY 08-07-2025
- PYPD 08-13-2025
- Dividend Yield
- EDRY N/A
- PYPD N/A
- EPS Growth
- EDRY N/A
- PYPD N/A
- EPS
- EDRY N/A
- PYPD N/A
- Revenue
- EDRY $55,867,583.00
- PYPD N/A
- Revenue This Year
- EDRY N/A
- PYPD N/A
- Revenue Next Year
- EDRY $28.27
- PYPD N/A
- P/E Ratio
- EDRY N/A
- PYPD N/A
- Revenue Growth
- EDRY 10.25
- PYPD N/A
- 52 Week Low
- EDRY $7.60
- PYPD $2.30
- 52 Week High
- EDRY $24.72
- PYPD $4.42
- Technical
- Relative Strength Index (RSI)
- EDRY 69.47
- PYPD 47.79
- Support Level
- EDRY $9.78
- PYPD $3.34
- Resistance Level
- EDRY $10.44
- PYPD $3.53
- Average True Range (ATR)
- EDRY 0.71
- PYPD 0.13
- MACD
- EDRY 0.10
- PYPD -0.05
- Stochastic Oscillator
- EDRY 56.90
- PYPD 6.82
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.